Shivi Shivi
Mind Matters Foundation, USA
Abstract Title: SynTheraX-OncoFusion: A CRISPR-Free, AI-Driven RNA Therapeutics Platform for Predicting and Suppressing Hyperplastic Resistance via HCRN Mapping, Synthetic siRNA Logic Gates, and 3D-Enabled Drug Design-Anchored in Glioblastoma with Pan-Cancer Translational Applicability